Carbohydrate linked organotin(iv) complexes as human topoisomerase Iα inhibitor and their antiproliferative effects against the human carcinoma cell line
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Carbohydrate linked organotin(iv) complexes as human topoisomerase Iα inhibitor and their antiproliferative effects against the human carcinoma cell line
Authors
Keywords
-
Journal
DALTON TRANSACTIONS
Volume 43, Issue 6, Pages 2534-2548
Publisher
Royal Society of Chemistry (RSC)
Online
2013-11-19
DOI
10.1039/c3dt51973b
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New modulated design and synthesis of quercetin–CuII/ZnII–Sn2IV scaffold as anticancer agents: in vitro DNA binding profile, DNA cleavage pathway and Topo-I activity
- (2013) Sartaj Tabassum et al. DALTON TRANSACTIONS
- A Chloro-Bridged Heterobimetallic (η6-Arene)ruthenium–Organotin Complex as an Efficient Topoisomerase Iα Inhibitor
- (2013) Rais Ahmad Khan et al. ORGANOMETALLICS
- Molecular drug design, synthesis and structure elucidation of a new specific target peptide based metallo drug for cancer chemotherapy as topoisomerase I inhibitor
- (2012) Sartaj Tabassum et al. DALTON TRANSACTIONS
- Design and synthesis of (S)- and (R)-enantiomers of [4-(2-hydroxy-1-phenylethylimino)pent-2-ol]dimethyltin(iv) and 2,2-dimethyl-4-phenyl-1,3,2-oxazastannolidine: in vitro antitumor activity against human tumor cell lines and in vivo assay of (S)-enantiomers
- (2012) Farukh Arjmand et al. DALTON TRANSACTIONS
- Carbohydrate-conjugate heterobimetallic complexes: synthesis, DNA binding studies, artificial nuclease activity and in vitro cytotoxicity
- (2011) Sartaj Tabassum et al. CARBOHYDRATE RESEARCH
- Study of the Anticancer Properties of Tin(IV) Carboxylate Complexes on a Panel of Human Tumor Cell Lines
- (2011) Lourdes Rocamora-Reverte et al. ChemMedChem
- Design, synthesis, characterization and DNA-binding studies of a triphenyltin(iv) complex of N-glycoside (GATPT), a sugar based apoptosis inducer: in vitro and in vivo assessment of induction of apoptosis by GATPT
- (2011) Sartaj Tabassum et al. Metallomics
- Rational Design of an Organometallic Glutathione Transferase Inhibitor
- (2009) Wee Han Ang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Structural modification of 3-arylisoquinolines to isoindolo[2,1-b]isoquinolinones for the development of novel topoisomerase 1 inhibitors with molecular docking study
- (2009) Hue Thi My Van et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Organometallic compounds in oncology: implications of novel organotins as antitumor agents
- (2009) Angela Alama et al. DRUG DISCOVERY TODAY
- Bioorganometallic fulvene-derived titanocene anti-cancer drugs
- (2008) Katja Strohfeldt et al. CHEMICAL SOCIETY REVIEWS
- Bioorganometallic chemistry—from teaching paradigms to medicinal applications
- (2008) Christian G. Hartinger et al. CHEMICAL SOCIETY REVIEWS
- Similar Biological Activities of Two Isostructural Ruthenium and Osmium Complexes
- (2008) Jasna Maksimoska et al. CHEMISTRY-A EUROPEAN JOURNAL
- Carbohydrate-Metal Complexes and their Potential as Anticancer Agents
- (2008) Christian Hartinger et al. CURRENT MEDICINAL CHEMISTRY
- Interaction of tributyltin(IV) chloride and a related complex [Bu3Sn(LSM)] with rat leukocytes and erythrocytes: Effect on DNA and on plasma membrane
- (2008) Maria Letizia Falcioni et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- DNA Interaction with Novel Antitumor Estradiol–Platinum(II) Hybrid Molecule: A Comparative Study with Cisplatin Drug
- (2007) Christophe N. N'soukpoé-Kossi et al. DNA AND CELL BIOLOGY
- Bleomycin-induced double-strand breaks in mitochondrial DNA of Drosophila cells are repaired
- (2007) Frederic Morel et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started